Benjamin Ory

13PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersMolecular targetsGenome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 20, 2026
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

|Jun 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.

Darrell Green, Roelof van Ewijk, Elisa Tirtei

|Apr 08, 2024
Super-enhancers: drivers of cells' identities and cells' debacles.

Mélanie Lavaud, Robel Tesfaye, Léa Lassous

|Jun 12, 2023
Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells.

Robel A Tesfaye, Melanie Lavaud, Céline Charrier

|Dec 11, 2022
The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway.

Lidia Rodriguez Calleja, Melanie Lavaud, Robel Tesfaye

|Jul 27, 2022
Origin and Therapies of Osteosarcoma.

Brice Moukengue, Morgane Lallier, Louise Marchandet

Pageof 3

Frequent Collaborators

5 joint publications

Franck Verrecchia

4 joint publications

Bénédicte Brounais-Le-Royer

2 joint publications

Frédéric Lézot

2 joint publications

Robel Tesfaye